|
ELAVL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.488270E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.957900E-03 |
| Normal-vs-Stage2 |
1.113600E-01 |
| Normal-vs-Stage3 |
3.377000E-01 |
| Normal-vs-Stage4 |
4.204400E-01 |
| Stage1-vs-Stage2 |
9.905600E-01 |
| Stage1-vs-Stage3 |
1.545600E-01 |
| Stage1-vs-Stage4 |
2.355200E-01 |
| Stage2-vs-Stage3 |
3.771600E-01 |
| Stage2-vs-Stage4 |
3.805200E-01 |
| Stage3-vs-Stage4 |
9.523200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.243600E-02 |
| Normal-vs-AfricanAmerican |
1.557580E-02 |
| Normal-vs-Asian |
8.073900E-02 |
| Caucasian-vs-AfricanAmerican |
6.758400E-02 |
| Caucasian-vs-Asian |
9.402600E-01 |
| AfricanAmerican-vs-Asian |
1.575990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.977600E-02 |
| Normal-vs-Female |
1.259720E-02 |
| Male-vs-Female |
5.459200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.780030E-03 |
| Normal-vs-Age(41-60Yrs) |
8.467600E-02 |
| Normal-vs-Age(61-80Yrs) |
7.030400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.021800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.357150E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.603400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.038000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.299600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.869200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.375600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.517880E-02 |
| Classical-VS-Follicular |
3.077800E-03 |
| Classical-VS-Other |
7.597600E-01 |
| Classical-VS-Normal |
3.974300E-04 |
| Tall-VS-Follicular |
8.992200E-01 |
| Tall-VS-Other |
3.651200E-01 |
| Tall-VS-Normal |
8.722800E-01 |
| Follicular-VS-Other |
4.859200E-01 |
| Follicular-VS-Normal |
9.956800E-01 |
| Other-VS-Normal |
2.897000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.197800E-02 |
| Normal-vs-N1 |
4.403200E-01 |
| N0-vs-N1 |
5.429200E-01 |
|
|
